Jul 28, 2026 07:02AM
Jul 28, 2026 07:00AM
Jun 22, 2026 04:10PM
Jun 22, 2026 04:10PM
Jun 18, 2026 08:00AM
Jun 18, 2026 08:00AM
Jun 8, 2026 07:01AM RedHill initiates enforcement of $10.9 million judgment in Korea
Jun 8, 2026 07:00AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
Apr 30, 2026 07:03AM
Apr 30, 2026 07:00AM
Apr 27, 2026 08:00AM
Apr 22, 2026 08:00AM RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
Mar 4, 2026 05:46PM
Feb 25, 2026 07:00AM
Jan 5, 2026 07:02AM
Jan 5, 2026 07:00AM
Dec 15, 2025 07:03AM
Dec 15, 2025 07:00AM
Dec 1, 2025 07:02AM RedHill Biopharma regains NASDAQ stockholders' equity compliance
Dec 1, 2025 07:00AM
Nov 4, 2025 12:02PM
Nov 4, 2025 09:30AM
Nov 4, 2025 09:30AM
Nov 4, 2025 09:30AM
Oct 22, 2025 04:51PM
Oct 22, 2025 04:50PM RedHill Biopharma Receives Nasdaq Staff Determination Notification
Oct 20, 2025 09:05AM
Oct 20, 2025 09:05AM
Oct 20, 2025 09:01AM
Oct 20, 2025 09:00AM
Oct 6, 2025 08:01AM
Oct 6, 2025 08:00AM
Sep 29, 2025 07:02AM RedHill Biopharma wins $10 million court judgment on appeal
Sep 29, 2025 07:00AM
Sep 5, 2025 07:00AM
Aug 20, 2025 09:03AM
Aug 20, 2025 09:00AM
Aug 18, 2025 09:03AM
Aug 18, 2025 09:00AM
Jul 21, 2025 09:01AM RedHill gets FDA guidance for Crohn's disease drug trial design
Jul 21, 2025 09:00AM
Jul 1, 2025 12:01PM
Jul 1, 2025 12:00PM
May 13, 2025 07:00AM
May 2, 2025 07:00AM
Apr 28, 2025 07:05AM
Apr 28, 2025 07:03AM RedHill Biopharma Secures Allowance of Key Chinese Patent Application for Proprietary COVID-19 Treatment, RHB-107
Apr 17, 2025 04:08PM

327,877 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All